Imperial College London

Prof. Diana Gorog

Faculty of MedicineNational Heart & Lung Institute

Honorary Senior Research Fellow



+44 (0)20 7034 8934d.gorog




Royal BromptonRoyal Brompton Campus





Consultant Cardiologist with a research interest in coronary thrombosis. 



Gorog DA, Gue YX, Chao T-F, et al., 2022, Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper, Thrombosis and Haemostasis, ISSN:0340-6245

Gue YX, Gorog DA, Lip GYH, 2022, Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?, Jama Cardiology, ISSN:2380-6583

Vandenbriele C, Arachchillage DJ, Frederiks P, et al., 2022, Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock, Journal of the American College of Cardiology, Vol:79, ISSN:0735-1097, Pages:1949-1962

Piccini JP, Caso V, Connolly SJ, et al., 2022, Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, Lancet, Vol:399, ISSN:0140-6736, Pages:1383-1390


Kanji R, Gue YX, Saw AM, et al., 2022, Does targeted temperature management increase the risk of stent thrombosis in survivors of out-of-hospital cardiac arrest? A single centre experience, OXFORD UNIV PRESS, ISSN:0008-6363

More Publications